netFormulary NHS
Cambridgeshire and Peterborough
Formulary
 Search
 Results

Looking for Olaratumab found 5 matches

Non Formulary BNF Category
  Olaratumab  (Lartruvo)
(Infusion)
Other antineoplastic drugs - 08.01.05


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update June 2019: Lartruvo▼ (olaratumab) - withdrawal of the EU marketing authorisation due to lack of efficacy (08.01.05)
link in drug section MHRA Letters sent to healthcare professionals in May 2019: Lartruvo▼ (olaratumab) - withdrawal of the EU marketing authorisation due to lack of therapeutic efficacy (08.01.05)
link in drug section MHRA Letters sent to healthcare professionals in May 2019: Lartruvo▼ (olaratumab) - withdrawal of the EU marketing authorisation due to lack of therapeutic efficacy (08.01.05)
link in drug section NICE TA465: Olaratumab in combination with doxorubicin for treating advanced soft tissue sarcoma (08.01.05)


 

netFormulary